MONTREAL, Sept. 23, 2015 /PRNewswire/ -- Tactio's remote patient monitoring platform TactioRPM™ is now registered at the U.S. Food and Drug Administration (FDA) as a Class 1 Medical Device Data System (MDDS).
TactioRPM combines science-based mobile apps, web tools, HIPAA-compliant secured cloud services and vendor-agnostic connected health device integrations to allow clinicians to view patient generated data remotely, provide educational content and engage patients in a new mobile-centric, connected healthcare relationship. In addition, TactioRPM provides a rich set of APIs for healthcare organization to build further data integration, process automation and specific applications. Global healthcare payers and providers rely on TactioRPM to deliver mobile patient engagement solutions exploiting the ubiquity of smartphones and tablets as well as the rapidly expanding healthcare Internet of Things (HC IoT) offering.
"We started at Tactio from an early mobile health vision into unchartered healthcare regulatory territories. Now that mobile health has entered the daily lives of millions in several countries, the landscape is clearer for developers, payers, providers and regulators which is a very positive sign of maturity and growth for the entire industry," said Michel Nadeau, P.Eng., CEO of Tactio Health Group. "Registration of TactioRPM as a Class 1 MDDS is a natural start for the growth of our platform's deployments in the U.S. healthcare market," he added.
For more information on TactioRPM FDA Class 1 registration, visit http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/ldetails.cfm?lid=465865.
About Tactio Health Group
Tactio Health Group, founded in 2009, helps innovative healthcare organizations worldwide tap the power of mobile and connected health to improve clinical research, remote care workflows and patient engagement. The TactioRPM (remote patient monitoring) digital platform for health professionals and patients combine mobile apps, web tools, HIPAA-compliant secured cloud services and vendor-agnostic connected health device integrations. TactioRPM is available as a complete end-to-end system and as a platform for innovative healthcare application developers to provide digital coaching for patients with hypertension, diabetes, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), atherosclerosis and obesity. Tactio apps have been downloaded by more than 4 million users in 135 countries and 17 languages.
For more information about Tactio, visit www.tactiohealth.com or follow @TactioHealth on Twitter.
SOURCE Tactio Health Group